Department of Obstetrics and Gynecology, University of Harran, School of Medicine, Sanliurfa, Turkey, Turkey.
Department of Endocrinology, University of Harran, School of Medicine, Sanliurfa, Turkey.
Ginekol Pol. 2020;91(6):320-323. doi: 10.5603/GP.a2020.0063.
The aim of this study was to evaluate the frequency of metabolic syndrome (MetS) and its components in patients with unexplained recurrent pregnancy loss (RPL).
A cross-sectional study was held including 115 patients with unexplained RPL who were referred to a tertiary center between December 2018 and December 2019. In the study, MetS was classified according to The National Cholesterol Education Program (NCEP) Adult Treatment Panel III (ATP III) criteria on the basis of metabolic risk factors. Frequency of MetS in the patients with unexplained RPL was investigated. The relationship between miscarriage rate and metabolic risk factors was also evaluated.
According to our study the percentage of MetS in patients with unexplained RPL was 24.4%. When evaluated according to different age groups, it was 18.4% in patients aged 20-29 years, and it was 27.8% in patients aged 30-39 years. At least having one of its components were high (82.6%) in all patients with unexplained RPL.
The percentage of MetS or of at least having one of its components were high in patients with unexplained RPL. Increased number of having MetS components were associated with increased miscarriage rate.
本研究旨在评估不明原因复发性流产(RPL)患者中代谢综合征(MetS)及其各组分的发生频率。
本研究为一项横断面研究,共纳入 2018 年 12 月至 2019 年 12 月期间于一家三级中心就诊的 115 例不明原因 RPL 患者。根据美国国家胆固醇教育计划成人治疗专家组第三版(ATP III)标准,基于代谢危险因素对 MetS 进行分类。本研究旨在调查不明原因 RPL 患者中 MetS 的发生频率,并评估流产率与代谢危险因素之间的关系。
根据本研究,不明原因 RPL 患者中 MetS 的发生率为 24.4%。按不同年龄组评估时,20-29 岁患者的发生率为 18.4%,30-39 岁患者的发生率为 27.8%。所有不明原因 RPL 患者均至少存在一项 MetS 组分,其发生率高达 82.6%。
不明原因 RPL 患者的 MetS 发生率或至少存在一项其组分的发生率均较高。MetS 组分数量的增加与流产率的增加相关。